Testing a New Imaging Agent to Identify Cancer

Clinical trial NCT04692831 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04692831
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

HER-2 Positive Malignant Carcinoma of Breast HER-2 Protein Overexpression HER2-positive Metastatic Breast Cancer

Start date: 2020-11-30
Primary completion: 2027-11-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.